UCLA researchers developed a $5,000 cancer treatment that can hunt tumors throughout the body. One blood donor could provide ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...

Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast ...

UCLA and UC Davis will co-lead a newly funded, multi-institutional clinical trial to evaluate whether artificial intelligence (AI) can help support radiologists in interpreting mammograms more ...

Add Yahoo as a preferred source to see more of our stories on Google. UCLA scientists created AlloCAR70-NKT, a ready-to-use immune cell therapy that targets kidney cancer from multiple angles—without ...